| Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR (NCT05635045) | Columbia University | 2022-07-08 |
| Study of Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis Patients (NCT05075798) | Centre Hospitalier Universitaire de Nīmes | 2021-10-25 |
| The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients (NCT04963985) | Peking University Third Hospital | 2021-06-01 |
| Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF (NCT05577819) | Massachusetts General Hospital | 2020-10-02 |
| Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery (NCT04611204) | University Hospital, Toulouse | 2020-10-01 |
| ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy (NCT04513600) | The Christ Hospital | 2020-08-01 |
| Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population (NCT05409833) | Universidade do Porto | 2020-06-01 |
| The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis. (NCT05814380) | Katarzyna Holcman | 2020-05-04 |
| Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery (NCT04276220) | Steen Hvitfeldt Poulsen | 2020-04-01 |
| Patient-Reported Outcome Measures in Wild-Type and Variant Cardiac Transthyretin Amyloidosis (NCT04563286) | University of Messina | 2020-02-22 |
| Screening for Systemic Amyloidosis Via the Ligamentum Flavum (NCT03923920) | The Cleveland Clinic | 2019-05-01 |
| Cardiac Amyloidosis Screening at Trigger Finger Release (NCT03886155) | The Cleveland Clinic | 2019-05-01 |
| Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant (NCT03862807) | Alnylam Pharmaceuticals | 2019-03-27 |
| Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (NCT03860935) | Eidos Therapeutics, a BridgeBio company | 2019-03-19 |
| HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) (NCT03759379) | Alnylam Pharmaceuticals | 2019-02-14 |
| PL_GNT01_ISR_Grant 53234273 (NCT06714019) | National Institute of Cardiology, Warsaw, Poland | 2019-02-11 |
| Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR) (NCT03591757) | Boston University | 2018-10-30 |
| Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study (NCT03588468) | Assistance Publique Hopitaux De Marseille | 2018-09-20 |
| Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP) (NCT02713880) | CENTOGENE GmbH Rostock | 2018-08-20 |
| Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis (NCT03431896) | The Cleveland Clinic | 2018-02-01 |
| Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis (NCT03352089) | University of Edinburgh | 2017-11-01 |
| Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology (NCT03190577) | Nantes University Hospital | 2017-09-21 |
| TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects (NCT03237494) | CENTOGENE GmbH Rostock | 2017-07-20 |
| Carpal Tunnel Syndrome and Amyloid Cardiomyopathy (NCT02792790) | The Cleveland Clinic | 2016-03-01 |
| Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis (NCT02016365) | Umeå University | 2012-02-01 |